Inventor
HOGE STEPHEN G
US21 patents
⚠️ This page may combine multiple inventors who share the name “HOGE STEPHEN G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MODERNATX INC
19 patentsUS9597380B2Mar 21, 2017
Terminally modified RNA
MODERNATX INC143 citations99
US11027025B2Jun 8, 2021
Compositions comprising synthetic polynucleotides encoding CRISPR related proteins and synthetic sgRNAs and methods of use
MODERNATX INC40 citations94
US10155029B2Dec 18, 2018
Terminally modified RNA
MODERNATX INC12 citations92
US10072057B2Sep 11, 2018
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
MODERNATX INC31 citations92
US9751925B2Sep 5, 2017
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
MODERNATX INC32 citations92
US11344504B1May 31, 2022
Combinations of mRNAs encoding immune modulating polypeptides and uses thereof
MODERNATX INC4 citations84
US11071716B2Jul 27, 2021
Combinations of mRNAs encoding immune modulating polypeptides and uses thereof
MODERNATX INC3 citations84
US10335486B2Jul 2, 2019
MRNA combination therapy for the treatment of cancer
MODERNATX INC8 citations84
US10258698B2Apr 16, 2019
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
MODERNATX INC12 citations79
US11185510B2Nov 30, 2021
Combinations of mRNAs encoding immune modulating polypeptides and uses thereof
MODERNATX INC1 citations73
US10973917B2Apr 13, 2021
MRNA combination therapy for the treatment of cancer
MODERNATX INC4 citations73
US11649461B2May 16, 2023
Polynucleotides encoding α-galactosidase A for the treatment of Fabry disease
MODERNATX INC1 citations71
US10519455B2Dec 31, 2019
Polynucleotides encoding alpha-galactosidase A for the treatment of Fabry disease
MODERNATX INC1 citations71
US10494636B2Dec 3, 2019
Polynucleotides encoding α-galactosidase A for the treatment of Fabry disease
MODERNATX INC3 citations71
US12023371B2Jul 2, 2024
Terminally modified RNA
MODERNATX INC0 citations62
US11708396B2Jul 25, 2023
Signal-sensor polynucleotides for the alteration of cellular phenotypes
MODERNATX INC0 citations62
US11660341B2May 30, 2023
mRNA combination therapy for the treatment of cancer
MODERNATX INC0 citations62
US11603399B2Mar 14, 2023
Long-lived polynucleotide molecules
MODERNATX INC0 citations62
US12090235B2Sep 17, 2024
Preparation of lipid nanoparticles and methods of administration thereof
MODERNATX INC1 citations51